fingolimod hydrochloride has been researched along with Experimental Hepatoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bode, C; Gräler, MH; Sensken, SC | 1 |
| Chu, AC; Fan, ST; Ho, JW; Lee, TK; Man, K; Ng, IO; Ng, KT; Poon, RT; Sun, CK; Sun, HC; Tang, ZY; Wang, XH; Xu, R; Xu, Y | 1 |
2 other study(ies) available for fingolimod hydrochloride and Experimental Hepatoma
| Article | Year |
|---|---|
Accumulation of fingolimod (FTY720) in lymphoid tissues contributes to prolonged efficacy.
Topics: Animals; Calcium; Chemotaxis; Chromatography, Liquid; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Liver Neoplasms; Liver Neoplasms, Experimental; Lymphoid Tissue; Mass Spectrometry; Organophosphates; Propylene Glycols; Rats; Receptors, Lysosphingolipid; Sphingosine; Spleen | 2009 |
FTY720: a promising agent for treatment of metastatic hepatocellular carcinoma.
Topics: Animals; Antigens, CD34; Carcinoma, Hepatocellular; Disease Models, Animal; Down-Regulation; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Liver Neoplasms, Experimental; Mice; Mice, Nude; Microcirculation; Neovascularization, Pathologic; Propylene Glycols; rac GTP-Binding Proteins; Sphingosine; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Wound Healing | 2005 |